highperformr logo

Cosmo's Overview

Total employees224
HeadquartersDublin
Founded2000

Cosmo Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing innovative products to treat selected gastrointestinal disorders and improve endoscopy quality measures, such as by aiding the detection of colonic lesions. Their portfolio includes treatments for conditions like Ulcerative Colitis, Irritable Bowel Syndrome with Diarrhea (IBS-D), and products used in colonoscopy procedures. Cosmo aims to address unmet medical needs in gastroenterology and endoscopy through targeted therapies and novel medical devices.

Where is Cosmo's Headquarters?

HQ Function

Serves as the global corporate headquarters, overseeing strategic direction, financial management, research and development coordination, and administrative functions for Cosmo Pharmaceuticals' worldwide operations.

Notable Features:

Modern office facility located in the Riverside Business Park, designed to support a collaborative and efficient work environment for its corporate and R&D leadership teams.

Work Culture:

A dynamic, science-driven, and patient-focused work culture. Emphasizes innovation, ethical practices, teamwork, and continuous improvement in the development of pharmaceutical solutions.

HQ Significance:

The Dublin headquarters is strategically important for Cosmo's global operations, leveraging Ireland's established position as a European hub for the pharmaceutical and life sciences industry, offering benefits in terms of talent pool and business environment.

Values Reflected in HQ: The headquarters' operations and environment aim to reflect Cosmo's core values of scientific excellence, integrity, innovation, and a commitment to improving patient outcomes in gastroenterology.

Location:

Cosmo Pharmaceuticals has a focused global presence with key operational centers in Europe and North America. Its headquarters are in Dublin, Ireland, with major manufacturing and R&D facilities in Lainate, Italy, and U.S. commercial operations based in San Diego, California. Cosmo's products are marketed and distributed in over 40 countries worldwide, either directly or through a network of licensing and distribution partners, enabling access to its specialized gastroenterology and endoscopy solutions across key international markets.

Street Address:

Riverside II, Mulhuddart

City:

Dublin

State/Province:

Dublin 15

Country:

Ireland

Cosmo's Global Presence

Lainate (MI), Italy

Address: Via C. Colombo 1, 20045 Lainate (MI), Italy

Serves as a key European manufacturing and R&D hub, supporting the development and supply of products for both European and international markets, benefiting from Italy's robust pharmaceutical sector.

San Diego, CA, USA

Address: 9171 Towne Centre Drive, Suite 455, San Diego, CA 92122, USA

Focuses on the strategic U.S. pharmaceutical market, driving commercialization efforts, engaging with healthcare professionals, and navigating the regulatory landscape specific to the United States.

Buying Intent Signals for Cosmo

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cosmo

As of April 2025, Cosmo' leadership includes:

Alessandro Della Chà - Chief Executive Officer
Niall Donnelly - Chief Financial Officer
Luigi Carlo Maresca - Chief Medical Officer
Stefano Selva - Chief Scientific Officer
Giovanni Di Napoli - Chief Commercial Operations GI & Endoscopy Officer
Helen Kendrick - Head of Legal & Compliance / Company Secretary

Investors of Cosmo

Cosmo has been backed by several prominent investors over the years, including:

Mauro Severino Ajani (and related parties)
Cassia Investments S.à r.l.
Decalia Asset Management SA
Zürcher Kantonalbank (Swisscanto)
Other institutional and private investors via public listing on SIX Swiss Exchange (COPN)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Over the last 12 months, Cosmo Pharmaceuticals strengthened its executive leadership, notably with the appointment of Giovanni Di Napoli to head its commercial operations for GI and Endoscopy, indicating a focus on enhancing its market presence and commercial strategy.

New Appointments:

Giovanni Di Napoli, Giovanni Di Napoli joined Cosmo Pharmaceuticals as Chief Commercial Operations GI & Endoscopy Officer, becoming a member of the Executive Committee. His role is pivotal in driving the company's commercial strategy for its gastroenterology and endoscopy portfolio.

Technology (Tech Stack) used by Cosmo

Discover the tools Cosmo uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cosmo Email Formats and Examples

Cosmo Pharmaceuticals likely utilizes standard corporate email formats. Based on common patterns for companies of its size and structure, a primary format is often [first_initial][last]@cosmopharma.com or [first].[last]@cosmopharma.com. For example, an employee named Jane Doe might have an email address like jdoe@cosmopharma.com.

[first_initial][last]@cosmopharma.com

Format

jdoe@cosmopharma.com

Example

75%

Success rate

News and media

Cosmo Pharmaceuticals N.V. Press ReleaseApril 25, 2024

Cosmo Announces Publication of Phase III Pivotal Study Results for Clascoterone Solution in JAAD

Cosmo Pharmaceuticals announced that the Phase III pivotal study results for its investigational drug Clascoterone solution for the treatment of Androgenetic Alopecia (AGA) were published in the peer-reviewed Journal of the American Academy of Dermatology (JAAD). This publication highlights the efficacy and safety data, representing a key milestone for the product's development....more

Cosmo Pharmaceuticals N.V. Press ReleaseFebruary 29, 2024

Cosmo Reports FY 2023 Results and Provides Outlook for FY 2024

Cosmo Pharmaceuticals released its full-year financial results for 2023, reporting total revenues of €101.8 million and an operating profit. The company highlighted strong performance from key products like Byfavo® and Winlevi® and provided a positive outlook for 2024, anticipating continued revenue growth and advancements in its clinical pipeline....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cosmo, are just a search away.